Medtech Spectrum: Discovering the Intersection of Medical Technology and Healthcare Advancements

Article Name Blood BanK

Mayo Clinic Labs and Progentec® Partner for Advanced Autoimmune Biomarker Testing

The collaboration aims to increase accessibility for providers and patients across the U.S. and select global markets....Read more

15th November, 2023

CORE Diagnostics expands footprint in South India with new specialised lab in Hyderabad

Anticipates a significant revenue boost of Rs 40 million ...Read more

06th November, 2023

GE Healthcare and Novo Nordisk Team Up for Non-Invasive Diabetes & Obesity Treatment

GE HealthCare a collaboration with Novo Nordisk to further advance the clinical and product development of peripheral focused ultrasound (PFUS). This is a novel technology that has potential to specifically regulate meta...Read more

20th October, 2023

FloBio's Bleeding Risk Diagnostic Test Earns FDA's Breakthrough Device Designation

Rapid Detection of Modern Blood Thinners Could Reduce Preventable Complications in US Hospitals...Read more

19th October, 2023

Labcorp Launches New Test to Accelerate Path to Diagnosis of Alzheimer's Disease

Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced the launch and national availability of its ATN Profile, a blood-based test that combines three, well-researched blood ...Read more

13th October, 2023

DELFI Diagnostics Introduces FirstLook Lung: A Breakthrough in Blood-Based Lung Cancer Screening

FirstLook Lung uses a breakthrough technology of whole-genome machine learning to analyze fragments of cell-free DNA that are markers of cancer in the blood...Read more

11th October, 2023

How blood-based protein biomarkers enable early detection and intervention of Alzheimer’s disease

Blood-based protein biomarkers have emerged as a promising tool for the early detection of Alzheimer's disease...Read more

11th September, 2023 | By Dr Joyce Ouyang, Managing Director, Cognitact Limited, Hong Kong

Mirxes receives US FDA’s breakthrough device designation for blood-based cancer detection test

GASTROClear is the first miRNA blood test and the first gastric cancer molecular test globally to receive FDA Breakthrough Device Designation...Read more

14th August, 2023

Improved Access to Alzheimer's Blood Test Through Beckman Coulter-Fujirebio Partnership

Collaboration Builds upon Fujirebio Expertise in Neurodegenerative Disease Assays and Beckman Coulter’s High Sensitivity, High Throughput, Global Installed Base of Access Family of Immunoassay Analyzers...Read more

18th July, 2023